Orano USA

Headquartered in Maryland, Orano USA is a leading technology and services provider for decommissioning shutdown nuclear energy facilities, used fuel management, federal site cleanup and closure, and the sale of uranium, conversion, and enrichment services to the U.S. commercial and federal markets. With its parent company Orano, Orano USA has more than 30 years’ experience in decontaminating and dismantling nuclear facilities, and more than 50 years’ experience securely transporting and storing used nuclear fuel.

NUCLEAR TRANSPORT AND USED FUEL SOLUTIONS

Orano TN, the Orano subsidiary in charge of nuclear logistics (formerly known as TN Americas), is a leader in the American nuclear industry offering innovative total systems solutions for used fuel and radioactive waste management and nuclear transportation.  While our hallmark is to bring the right technology to the customer at the right time, our success is based on unparalleled human performance initiatives, a dedication to safety first, transparent pricing and business integrity that combine to ensure our customers get “as promised” cost savings and superior results.  Orano TN's talented team of seasoned nuclear professionals delivers engineering, technical and logistics expertise. Thus more than 50 percent of America’s nuclear plants rely on Orano TN's quality products and highly skilled teams to ensure a consistently high level of operational excellence.  Our state-of-the-art solutions deliver safe, error-free, and low-risk used fuel storage and nuclear transportation, and our engineering services drive innovation across the fuel cycle materials market.

ORANO MED - NUCLEAR THERAPY

Orano Med (formerly AREVA Med) is an Orano subsidiary specializing in the development of innovative therapies to fight cancer. Orano Med has developed new processes for producing high purity lead-212 (²¹²Pb), a rare radioactive isotope that is currently at the heart of promising nuclear medicine research.  This rare isotope is used in alpha radioimmunotherapy, a powerful anticancer therapy which offers great potential for combating certain very agressive types of cancer.